Is a complete INTS research report available?

No complete published report is available for Intensity Therapeutics, Inc. (INTS) on this page. Market-directory data, when present, is not a substitute for a reviewed stock analysis.

Intensity Therapeutics, Inc. (INTS)

NASDAQ: INTS · USD

$4.05

-0.28 (-6.5%)· Recorded snapshot

Coverage state: Market snapshot only — no published research

Market snapshot recorded 2026-07-31 02:00 UTC. No published research is attached to this ticker. Prices and fundamentals on this server-rendered page are dated snapshots, not a real-time trading feed.

On-demand research

Generate the first INTS analysis

Start the full research workflow when this ticker is ready in our data system.

Market cap	10.9M
Net income (ttm)	-10.7M
EPS (ttm)	-$5.82
Shares out	2.7M
Volume	44,386
Beta	3.05
Price target	$24.8	+512.3%

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Net income (ttm): -10.7M
EPS (ttm): -$5.82
Market cap: 10.9M

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
ALNY	Alnylam Pharmaceuticals, Inc.	27.4B	36.9x	5.7x	96.6%	+47.5%	-37.8%	Strong Buy
ARGX	argenx SE	53.8B	31.3x	10.1x	50.6%	+58.8%	+45.7%	Strong Buy
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Hold

All INTS indicators

Market & fundamental data

Available fields

167

Groups with data

Currency

USD

Showing 167 of 167 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001567264
Company name	Intensity Therapeutics, Inc.
Country	United States
Country code	US
Cusip	45828J202
Employees	7
Employees Change	1%
Employees Change Percent	16.67
Enterprise value	$803,421
Exchange	NASDAQ
Financial currency	USD
First seen	2026-05-09
Industry	Biotechnology
IPO Date	2023-06-30
Isin	US45828J2024
Last refreshed	2026-07-31
Market cap	$10.9M
Market cap category	Nano-Cap
Price	$4.05
Price currency	USD
Sector	Healthcare
Sector PE	45.64
Sector PE Fwd	24.21
Sic	2836
Symbol	INTS
Website	https://intensitytherapeutics.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-97.68%
P/B ratio	1.03x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Net Income	$-10.7M
Net Income Growth Quarters	5%
Net Income Growth Years	1%
Profit Per Employee	$-1.5M
ROA	-90.39
Roa5y	-85.65
ROCE	-110.5
ROE	-207.4
ROIC	-131.6

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	-49.56%
Cagr3y	-69.49%
EPS Growth Quarters	5
EPS Growth Years	4
Revenue Growth Years	0x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Assets	$12.3M
Cash	$10.2M
Current Assets	$10.9M
Current Liabilities	$2.2M
Debt	$102,000
Debt Equity	$0.01
Equity	$10M
Liabilities	$2.3M
Long Term Assets	$1.4M
Long Term Liabilities	$70,000
Net Cash	$10.1M
Net Cash By Market Cap	$92.66
Net Cash Growth	1,171.05%
Net Debt Equity	$-1.02
Tangible Book Value	$10M
Tangible Book Value Per Share	$3.93
WACC	20.83

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	4.86
Net Working Capital	$-1.5M
Quick ratio	4.57
Working Capital	$8.7M

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-221.96%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	-49.53%
200-day SMA	7.39
3Y total return	-97.16%
50-day SMA	4.31
50-day SMA vs 200-day SMA	50under200
All Time High	286
All Time High Change	-98.58%
All Time High Date	2023-12-08
All Time Low	3.51
All Time Low Change	15.38%
All Time Low Date	2026-06-09
ATR	0.24
Beta	3.05
Beta1y	2
Beta2y	0.38
Ch YTD	-60.51
High	4.42
High52	43.5
High52 Date	2025-10-30
High52ch	-90.69%
Low	4.01
Low52	3.51
Low52 Date	2026-06-09
Low52ch	15.39%
Ma50ch	-6.05%
Price vs 200-day SMA	-45.18%
RSI	35.89
RSI Monthly	35.13
RSI Weekly	36.07
Sharpe ratio	0.54x
Sortino ratio	2.74
Total Return	-221.96%
Tr YTD	-60.51
Tr1m	0.37%
Tr1w	-8.58%
Tr3m	-21.36%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Analyst Count	5
Analyst Count Top	0
Analyst Ratings	Strong Buy
Earnings EPS Estimate	$-0.78
Operating Income	$-11.1M
Price target	$24.8
Price Target Change	$512

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	2,476,881%
Float Percent	91.64%
Shares Insiders	5.38%
Shares Institutions	7.92%
Shares Out	2,702,820
Shares Qo Q	8.76%
Shares Yo Y	221.96%
Short Float	6.56%
Short Ratio	2.4
Short Shares	6.02

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted OCF	-11,022,000
Average Volume	35,651.2x
Bv Per Share	3.93
Ch1m	0.37
Ch1w	-8.58
Ch1y	-49.53
Ch3m	-21.36
Ch3y	-97.16
Ch6m	-56.81
Change	-6.47%
Change From Open	-6.03
Close	4.33
Days Gap	-0.46
Dollar Volume	179,763.3
Earnings Date	2026-08-05
Earnings Time	amc
EBIT	$-11.1M
EBITDA	$-11.1M
EPS	$-5.82
F Score	2
Financing CF	18,386,000
Fiscal Year End	December
Founded	2,012
Ipr	-19
Iprfo	-97.28
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-05-07
Last Report Date	2026-03-31
Last Split Date	2026-02-19
Last Split Type	Reverse
Last10k Filing Date	2026-03-27
Ma150	6.3
Ma150ch	-35.71%
Ma20	4.61
Ma20ch	-12.22%
Net CF	9,316,000
Next Earnings Date	2026-08-10
Open	4.31
Optionable	No
Position In Range	10.19
Ppne	89,000
Price Date	2026-07-30
Ptbv Ratio	1.1
Relative Volume	1.25x
Share Based Comp	1,952,000
Tr6m	-56.81%
Us State	Connecticut
Volume	44,386

Intensity Therapeutics, Inc. (INTS)

Coverage state: Market snapshot only — no published research

Generate the first INTS analysis

Price

Financial snapshot

Fair-value bridge

Analyst consensus

Latest news · INTS

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All INTS indicators

Profile and market data

Valuation

Profitability

Growth

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Analyst estimates

Ownership and float

Other indicators

Deeper analysis on INTS

Frequently asked questions